Investigation by immunohistochemistry (IHC) on an additional 4 peripheral nerve tumors from the Pennsylvania State University core facility indicated that all of them were also positive for IL13Rα2 (Fig 2). The gene discussed is IL13RA2; the disease is peripheral nervous system neoplasm.